= 0.25 Inventors with similar research interests:
Location History:
- Wuppertal, DE (1985 - 1989)
- Ekrath, DE (1998 - 2011)
- Erkrath, DE (1989 - 2024)
Company Filing History:
66 out of 12,157 
26 out of 721 
17 out of 378 
Years Active: 1985-2024
Title: Andreas Knorr: A Prolific Innovator in the Field of Biomedical Research
Introduction:
Andreas Knorr, a resident of Erkrath, DE, is an exceptional scientist renowned for his contributions in the field of biomedical research. With an impressive portfolio of 119 patents, Knorr has played a vital role in the development of novel pharmaceutical compounds for the treatment and prevention of diseases, most notably cardiovascular disorders. In this article, we will delve into his latest patents, career highlights, and notable collaborations that have shaped his remarkable journey in the world of innovation and patents.
Latest Patents:
One of Knorr's recent patents involves novel substituted 5-fluoro-1H-pyrazolopyridines, their synthesis processes, and their potential use in the treatment and prophylaxis of diseases. Specifically, these compounds demonstrate promising efficacy in managing cardiovascular disorders. This innovation showcases Knorr's commitment to advancing therapeutic options in an area of significant medical need.
Another noteworthy patent developed by Knorr focuses on the utilization of branched 3-phenylpropionic acid derivatives for the treatment and prevention of diseases, particularly cardiovascular conditions. This novel class of compounds, containing a branched or cyclic alkyl substituent, holds substantial potential in the development of effective medications to address cardiovascular ailments.
Career Highlights:
Throughout his distinguished career, Knorr has made substantial contributions to the pharmaceutical and biomedical industry. Notably, he has worked with renowned companies such as Bayer Aktiengesellschaft and Bayer Intellectual Property GmbH, where he has played a pivotal role in driving research and development efforts. Knorr's expertise and dedication have significantly contributed to the advancement of innovative therapies and pharmaceutical discoveries.
Collaborations:
Collaboration often fuels groundbreaking advancements, and Knorr understands this well. His collaborative efforts alongside esteemed colleagues like Johannes-Peter Stasch and Stanislav Kazda have been instrumental in pushing the boundaries of scientific knowledge and the development of new therapeutic compounds. These collaborations have fostered an environment of innovation, leading to the successful patenting of breakthrough discoveries.
Conclusion:
Andreas Knorr's impact in the biomedical field is undeniable, with an impressive patent portfolio comprising 119 patents. His latest patents involving substituted 5-fluoro-1H-pyrazolopyridines and branched 3-phenylpropionic acid derivatives demonstrate his commitment to enhancing treatment options for cardiovascular disorders. Through his collaborations and extensive industry experience, Knorr continues to contribute significantly to the advancement of biomedical research and the improvement of patient care worldwide.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.